Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in Lisbon Merck presents phase 3 STRIDE-13 trial results at ESCMID conference in L...

New phase 4 results show sustained symptom relief and improved patient outcomes New phase 4 results show sustained symptom relief and improved patient...

Abcuro has appointed George Eldridge as chief financial officer Abcuro has appointed George Eldridge as chief financial officer

Early data reveals strong response rates in ovarian cancer cohort Early data reveals strong response rates in ovarian cancer cohort

New partnership aims to fast-track mRNA therapies from lab to clinic New partnership aims to fast-track mRNA therapies from lab to clinic

First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex

Novel orexin receptor agonist shows potential to improve wakefulness Novel orexin receptor agonist shows potential to improve wakefulness

Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain Topical TRPV1 antagonist shows promise in heat-induced neuropathic pain

Survey reveals lack of awareness need for greater clarity Survey reveals lack of awareness need for greater clarity

Trial explores regenerative macrophage therapy for liver disease Trial explores regenerative macrophage therapy for liver disease